5'-O-DMTr-2'-O-MOE inosine 3'-P-methyl phosphonamidite

This modified inosine nucleoside analog demonstrates selective antitumor activity against indolent lymphoid malignancies by disrupting DNA synthesis and promoting apoptosis. Its research applications include in vitro studies of nucleotide metabolism and in vivo models for investigating targeted therapies for slow-growing lymphoproliferative disorders.